Group items tagged

One of the day's biggest gainers and biggest losers both came from the healthcare sector on news of a planned buyout and negative results from a clinical trial.

Stocks near their 52-week high are rarely an appealing buy for many value investors, but here are five names that could have the potential to keep growing anyway.

While biotech is not an industry for investors who are faint of heart, the potential for big returns can still make it attractive.

Deep differences among Super Committee members on opinion over tax and spending reforms made it impossible to strike a compromise, marking another market-negative catalyst.

In honor of the Thanksgiving holiday, we're offering up some folks with something to be thankful for in 2011, whether it be big returns or a lucky break.

The report is titled as 'General Anesthesia Drugs Market: Opportunity Analysis and Future Assessment 2022-2030'. An overview of conceptual frameworks, analytical approaches of the General Anesthesia Drugs market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.

The report is titled as 'Non-alcoholic Steatohepatitis (NASH) Biomarkers Market: Opportunity Analysis and Future Assessment 2022-2030'. An overview of conceptual frameworks, analytical approaches of the Non-alcoholic Steatohepatitis (NASH) Biomarkers market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.

The report is titled as 'Small Molecule API Market: Opportunity Analysis and Future Assessment 2022-2030'. An overview of conceptual frameworks, analytical approaches of the Small Molecule API market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.